Suchergebnisse - "Chan, Cheng-Wei"

PubPharm (18)

1

Taiwan's successful containment of COVID-19 during 2020-2021

enthalten in: Journal of the Formosan Medical Association = Taiwan yi zhi | 2024

von Niu, K. | Cheng, Y. | Chan, C. | +3

2

SARS-CoV-2 rapid antigen testing positive rate in community testing stations as an indicator for COVID-19 epidemic trend, Taipei, Taiwan, May to August 2021

enthalten in: Journal of the Formosan Medical Association = Taiwan yi zhi | 2023

von Niu, K. | Cheng, Y. | Chan, C. | +3

3

Walking against traffic and pedestrian injuries in the United Kingdom : new insights

enthalten in: BMC public health | 2023

von Widodo, A. | Chen, C. | Chan, C. | +3

4

Migrating hook wire that travels to the heart via the bloodstream : A case report

enthalten in: Medicine | 2023

von Chen, K. | Wu, C. | Wei, H. | +2

5

Evaluating the effect of drunk driving on fatal injuries among vulnerable road users in Taiwan : a population-based study

enthalten in: BMC public health | 2022

von Lin, H. | Chan, C. | Wiratama, B. | +6

6

Evaluating the effect of drunk driving on fatal injuries among vulnerable road users in Taiwan: a population-based study

enthalten in: BMC public health | 2022

von Lin, H. | Chan, C. | Wiratama, B. | +6

7

Comparison of different novel COVID-19 swab testing devices

enthalten in: Journal of the Formosan Medical Association = Taiwan yi zhi | 2022

von Chan, C. | Huang, C.

8

Three-Minute Step Test for Predicting Acute Mountain Sickness : A Post Hoc Analysis of Rhodiola Crenulata Extract for Prevention of Acute Mountain Sickness, a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial

enthalten in: Journal of acute medicine | 2018

von Lo, H. | Chen, L. | Su, D. | +8

9

Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients : a nationwide cohort observational study

enthalten in: Cardiovascular diabetology | 2018

von Chan, C. | Yu, C. | Lin, J. | +9

10

Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study

enthalten in: Cardiovascular diabetology | 2018

von Chan, C. | Yu, C. | Lin, J. | +9